TORS FOR TONSILS AND BOT
TORS is associated with an incremental cost-effectiveness ratio of $8619
compared with traditional EUA alone
JK Byrd, Otolaryngol Head
Neck Surg 2014
IDENTIFICATION OF THE PRIMARY TUMOR
mercoledì 29 giugno 16